Health In Tech, Inc. (HIT) Form 8-K — Oct 16, 2026
Health In Tech received a Nasdaq notice on October 14, 2026 stating it is out of compliance with independent director and audit committee requirements following the August 10 resignation of director Sanjay Shrestha from the Board and Audit Committee. The company has until the earlier of its next annual meeting or August 10, 2027 to cure, and expects a new independent director nominee elected at the November 10, 2026 annual meeting. Separately, the company received an October 12 letter flagging that its Class A common stock closed below the $1.00 minimum bid price for 30 consecutive business days.
Key figures
- Board size
- 4
- Independent directors
- 2
- Bid price cure deadline
- April 12, 2027
- Bid price requirement usd
- 1
- Audit committee cure deadline
- August 10, 2027
- Additional compliance period days
- 180
- Consecutive business days below bid
- 30
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.